<DOC>
	<DOC>NCT02365272</DOC>
	<brief_summary>The aim of the study is the evaluation of PK/PD target attainment of amikacin in ED patients with severe sepsis and septic shock.</brief_summary>
	<brief_title>Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<criteria>patients admitted at the emergency department with a diagnosis of severe sepsis or septic shock in whom amikacin is indicatied &lt; 18 years pregnancy burns amikacin treatment in the previous 2 weeks known allergy to aminoglycosides Do Not Reanimate Code â‰¥ 2 Hospitalized patients with a prolonged deep venous or arterial catheder Continuous renal replacement, intermittent hemodialysis and death within the time of start of amikacin replacement and 1 hour later</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>pharmacokinetics</keyword>
	<keyword>aminoglycosides</keyword>
</DOC>